You can buy or sell Smith & Nephew and other stocks, options, and ETFs commission-free!
Smith & Nephew PLC engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom. The listed name for SNN is Smith & Nephew plc.
Roland D. Diggelmann
52 Week High
52 Week Low
UPDATE 3-Smith+Nephew sees further pandemic pain as annual profit slumps
* FY trading profit falls, misses average estimate * Co encouraging employees to get vaccinated * COVID-19 impact to continue into H1 2021 * Shares fall as m
Smith & Nephew 2020 profit and revenue fall
Smith & Nephew PLC said Thursday that 2020 pretax profit fell sharply on lower revenue, and that the outlook reflects the likely continuation of the effects of
— per share
Available Feb 18, Pre-Market